Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.37 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | IDO1 | P14902 | 2/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22344264 | 0.84 | GAA (0.33) | MAPTGAA | |
| SCHEMBL13009316 | 0.82 | MTNR1A (0.38) | MAPTGAAMEN1KMT2A | |
| SCHEMBL12496506 | 0.77 | TNKS2 (0.38) | MAPTGAAARBRD4CREBBP | |
| SCHEMBL6312690 | 0.76 | CHRNB2 (0.33) | — | |
| SCHEMBL24611560 | 0.76 | GAA (0.39) | MAPTGAAARBRD4CREBBP | |
| SCHEMBL6308525 | 0.76 | CHRNB2 (0.33) | — | |
| SCHEMBL7335844 | 0.74 | PRCP (0.46) | IDO1 | |
| SCHEMBL18068338 | 0.74 | GAA (0.40) | MAPTGAAARBRD4CREBBP | |
| SCHEMBL7929256 | 0.73 | GAA (0.42) | MAPTGAAARBRD4CREBBP | |
| SCHEMBL22361781 | 0.73 | IDO1 (0.48) | TSHRIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210252184-A1 | WATER-ABSORBING MATERIAL AND USES THEREOF | 7905122 CANADA INC. (CA) | 2021-08-19 | — | — | US | claimed |
| EP-3729442-A1 | MOLECULE-BASED EQUATION ORIENTED REACTOR SIMULATION SYSTEM AND ITS MODEL REDUCTION | Aspen Technology, Inc. (US) | 2020-10-28 | — | — | EP | claimed |
| US-20190228843-A1 | Molecule-Based Equation Oriented Reactor Simulation System And Its Model Reduction | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2019-07-25 | — | — | US | claimed |
| EP-3436813-A1 | WATER-ABSORBING MATERIAL AND USES THEREOF | 7905122 Canada Inc. (CA) | 2019-02-06 | — | — | EP | claimed |
| WO-2017165953-A1 | WATER-ABSORBING MATERIAL AND USES THEREOF | 7905122 CANADA INC. (CA) | 2017-10-05 | — | — | WO | claimed |
| US-20260048169-A1 | Water-Absorbing Material and Uses Thereof | 7905122 CANADA INC (CA) | 2026-02-19 | — | — | US | disclosed |
| US-12521466-B2 | Water-absorbing material and uses thereof | 7905122 CANADA INC. (CA) | 2026-01-13 | — | — | US | disclosed |
| US-20250345212-A1 | URINE TESTING GARMENT | REHLING BARBARA (US) | 2025-11-13 | — | — | US | disclosed |
| CN-112041001-B | Peritoneal dialysis systems and related methods | 费森尤斯医疗保健控股公司 | 2024-09-06 | — | — | CN | disclosed |
| EP-3762062-B1 | PERITONEAL DIALYSIS SYSTEMS AND RELATED METHODS | FRESENIUS MEDICAL CARE HOLDINGS INC (US) | 2024-02-28 | — | — | EP | disclosed |
| US-11913884-B2 | Visible light-activated dyes and methods of use thereof | WILLIAM MARSH RICE UNIVERSITY (US) | 2024-02-27 | — | — | US | disclosed |
| US-11877506-B2 | Polycyclic aromatic compound | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2024-01-16 | — | — | US | disclosed |
| US-20090054649-A1 | Bridged Organosilane and Production Method Thereof | KABUSHIKI KAISHA TOYOTA CHUO KENKYUSHO (JP) | 2009-02-26 | — | — | US | disclosed |
| US-20070155952-A1 | Blue electroluminescent polymer, method of preparing blue electroluminescent polymer, and organic electroluminescent device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-07-05 | — | — | US | disclosed |
| US-20070155952-A1 | Blue electroluminescent polymer, method of preparing blue electroluminescent polymer, and organic electroluminescent device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-07-05 | — | — | US | disclosed |
| US-20070155952-A1 | Blue electroluminescent polymer, method of preparing blue electroluminescent polymer, and organic electroluminescent device employing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-07-05 | — | — | US | disclosed |
| WO-2007041593-A2 | ANTI-SCARRING DRUG COMBINATIONS AND USE THEREOF | COMBINATORX, INCORPORATED (US) | 2007-04-12 | — | — | WO | disclosed |
| EP-0785932-A1 | PYRROLYL TETRAHYDROBENZOQUINOXALINE DIONES, THEIR PREPARATION AND USE AS GLUTAMATE RECEPTOR ANTAGONISTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-07-30 | — | — | EP | disclosed |
| US-5576432-A | Process for the manufacture of dihydropyrimidines | EASTMAN KODAK COMPANY (US) | 1996-11-19 | — | — | US | disclosed |
| WO-1996011922-A1 | PYRROLYL TETRAHYDROBENZOQUINOXALINE DIONES, THEIR PREPARATION AND USE AS GLUTAMATE RECEPTOR ANTAGONISTS | BASF AKTIENGESELLSCHAFT (DE) | 1996-04-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11877506-B2 | Polycyclic aromatic compound | F11, C1R, RNF31 | MAPT 4416/4885GAA 4700/4885AR 458/4885 |
| US-20090054649-A1 | Bridged Organosilane and Production Method Thereof | C5, CCNE1, QSOX1 | MAPT 3900/4885GAA 2452/4885AR 4738/4885 |
| US-20260048169-A1 | Water-Absorbing Material and Uses Thereof | HCN4, KCNN1, SLC9A1 | MAPT 1010/4885GAA 1906/4885AR 1373/4885 |
| US-11913884-B2 | Visible light-activated dyes and methods of use thereof | HCCS, CLTB, ALDH1A2 | MAPT 2009/4885GAA 592/4885AR 4279/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.